全文获取类型
收费全文 | 55672篇 |
免费 | 3499篇 |
国内免费 | 110篇 |
专业分类
耳鼻咽喉 | 529篇 |
儿科学 | 2302篇 |
妇产科学 | 1514篇 |
基础医学 | 6969篇 |
口腔科学 | 539篇 |
临床医学 | 8564篇 |
内科学 | 9579篇 |
皮肤病学 | 758篇 |
神经病学 | 5329篇 |
特种医学 | 977篇 |
外科学 | 4606篇 |
综合类 | 589篇 |
一般理论 | 109篇 |
预防医学 | 7764篇 |
眼科学 | 760篇 |
药学 | 3635篇 |
中国医学 | 61篇 |
肿瘤学 | 4697篇 |
出版年
2023年 | 290篇 |
2022年 | 432篇 |
2021年 | 1017篇 |
2020年 | 694篇 |
2019年 | 1051篇 |
2018年 | 1203篇 |
2017年 | 977篇 |
2016年 | 1059篇 |
2015年 | 1238篇 |
2014年 | 1712篇 |
2013年 | 2729篇 |
2012年 | 3930篇 |
2011年 | 4245篇 |
2010年 | 2357篇 |
2009年 | 2128篇 |
2008年 | 3836篇 |
2007年 | 4081篇 |
2006年 | 3933篇 |
2005年 | 4078篇 |
2004年 | 3872篇 |
2003年 | 3642篇 |
2002年 | 3363篇 |
2001年 | 473篇 |
2000年 | 355篇 |
1999年 | 482篇 |
1998年 | 688篇 |
1997年 | 612篇 |
1996年 | 483篇 |
1995年 | 482篇 |
1994年 | 427篇 |
1993年 | 339篇 |
1992年 | 244篇 |
1991年 | 210篇 |
1990年 | 187篇 |
1989年 | 198篇 |
1988年 | 188篇 |
1987年 | 169篇 |
1986年 | 162篇 |
1985年 | 163篇 |
1984年 | 186篇 |
1983年 | 169篇 |
1982年 | 215篇 |
1981年 | 207篇 |
1980年 | 155篇 |
1979年 | 94篇 |
1978年 | 112篇 |
1977年 | 52篇 |
1976年 | 57篇 |
1975年 | 45篇 |
1974年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
Christine D Pollard Susan M Sigward Susumu Ota Karen Langford Christopher M Powers 《Clinical journal of sport medicine》2006,16(3):223-227
OBJECTIVE: To examine the influence of in-season injury prevention training on hip and knee kinematics during a landing task. DESIGN: Longitudinal pre-post intervention study. SETTING: Testing sessions were conducted in a biomechanics research laboratory. PARTICIPANTS: Eighteen female soccer players between the ages of 14 and 17 participated in this study. All subjects were healthy with no current complaints of lower extremity injury. INTERVENTIONS: Testing sessions were conducted prior to and following a season of soccer practice combined with injury prevention training. MAIN OUTCOME MEASUREMENTS: During each testing session three-dimensional kinematics were collected while each subject performed a drop landing task. Peak hip and knee joint angles were measured during the early deceleration phase of landing and compared between pre- and post-training using paired t-tests. RESULTS: Following a season of soccer practice combined with injury prevention training, females demonstrated significantly less hip internal rotation (7.1 degrees vs. 1.9 degrees; P = 0.01) and significantly greater hip abduction (-4.9 degrees vs. -7.7 degrees; P = 0.02). No differences in knee valgus or knee flexion angles were found post-season. CONCLUSIONS: Female soccer players exhibited significant changes in hip kinematics during a landing task following in-season injury prevention training. Our results support the premise that a season of soccer practice combined with injury prevention training is effective in altering lower extremity motions that may play a role in predisposing females to ACL injury. 相似文献
35.
Molecular determinants of cetuximab efficacy. 总被引:17,自引:0,他引:17
Daniel Vallb?hmer Wu Zhang Michael Gordon Dong Yun Yang Jim Yun Oliver A Press Katrin E Rhodes Andy E Sherrod Syma Iqbal Kathleen D Danenberg Susan Groshen Heinz-Josef Lenz 《Journal of clinical oncology》2005,23(15):3536-3544
PURPOSE: To investigate whether mRNA expression levels of cyclin D1 (CCND1), cyclooxygenase 2 (Cox-2), epidermal growth factor receptor (EGFR), interleukin 8 (IL-8), and vascular endothelial growth factor (VEGF), all members of the EGFR signaling pathway, are associated with clinical outcome in patients with EGFR-expressing metastatic colorectal cancer (CRC) treated with cetuximab. PATIENTS AND METHODS: Thirty-nine patients with metastatic CRC, refractory to both irinotecan and oxaliplatin, were enrolled on IMCL-0144 and treated with single-agent cetuximab. The intratumoral mRNA levels of CCND1, Cox-2, EGFR, IL-8, and VEGF were assessed from paraffin-embedded tissue samples using laser-capture microdissection and quantitative real-time polymerase chain reaction. RESULTS: There were 21 women and 18 men with a median age of 64 years (range, 35 to 83 years). Higher gene expression levels of VEGF were associated with resistance to cetuximab (P = .038; Kruskal-Wallis test). The combination of low gene expression levels of Cox-2, EGFR, and IL-8 was significantly associated with overall survival (13.5 v 2.3 months; P = .028; log-rank test). Both findings were independent of skin toxicity that was itself significantly correlated to survival. Patients with a lower mRNA amount of EGFR had a longer overall survival compared with patients that had a higher mRNA amount (7.3 v 2.2 months; P = .09; log-rank test). Patients with lower expression of Cox-2 had a significantly higher rate of grade 2 to 3 skin reactions under cetuximab treatment. CONCLUSION: This pilot study suggests that gene expression levels of Cox-2, EGFR, IL-8, and VEGF in patients with metastatic CRC may be useful markers of clinical outcome in single-agent cetuximab treatment. 相似文献
36.
Najat C Daw Wayne L Furman Clinton F Stewart Lisa C Iacono Mark Krailo Mark L Bernstein Janet E Dancey Rose Anne Speights Susan M Blaney James M Croop Gregory H Reaman Peter C Adamson 《Journal of clinical oncology》2005,23(25):6172-6180
PURPOSE: Epidermal growth factor receptor is expressed in pediatric malignant solid tumors. We conducted a phase I trial of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in children with refractory solid tumors. PATIENTS AND METHODS: Gefitinib (150, 300, 400, or 500 mg/m2) was administered orally to cohorts of three to six patients once daily continuously until disease progression or significant toxicity. Pharmacokinetic studies were performed during course one (day 1 through 28). RESULTS: Of the 25 enrolled patients, 19 (median age, 15 years) were fully evaluable for toxicity and received 54 courses. Dose-limiting toxicity was rash in two patients treated with 500 mg/m2 and elevated ALT and AST in one patient treated with 400 mg/m2. The maximum-tolerated dose was 400 mg/m2/d. The most frequent non-dose-limiting toxicities were grade 1 or 2 dry skin, anemia, diarrhea, nausea, and vomiting. One patient with Ewing's sarcoma had a partial response. Disease stabilized for 8 to > or = 60 weeks in two patients with Wilms' tumor and two with brainstem glioma (one exophytic). At 400 mg/m2, the median peak gefitinib plasma concentration was 2.2 microg/mL (range, 1.2 to 3.6 microg/mL) and occurred at a median of 2.3 hours (range, 2.0 to 8.3 hours) after drug administration. The median apparent clearance and median half-life were 14.8 L/h/m2 (range, 3.8 to 24.8 L/h/m2) and 11.7 hours (range, 5.6 to 22.8 hours), respectively. Gefitinib systemic exposures were comparable with those associated with antitumor activity in adults. CONCLUSION: Oral gefitinib is well tolerated in children. Development of the drug in combination with cytotoxic chemotherapy will be pursued. 相似文献
37.
38.
39.
40.